The Food and Drug Administration (FDA) entered another period of uncertainty this week following the resignation of Commissioner Marty Makary after just 13 months leading the agency. Dr. Makary’s departure comes ahead of a Senate Appropriations Committee hearing scheduled for tomorrow on the FDA’s budget and follows months of internal disruption, including mass layoffs, persistent turnover among senior officials, tensions… (Colocho, May 12, 2026) #Artificial Intelligence, #Coverage Decisions, #Food and Drug Administration, #Tobacco